Ontrak Health Demonstrates Significant Improvement in Members’ Quality of Life from ReQoL Mental Health Assessment
2024年9月12日 - 9:00PM
ビジネスワイヤ(英語)
Ontrak, Inc. (NASDAQ: OTRK), a leading AI-powered and
technology-enabled behavioral healthcare company, announced
significant findings from the first two-quarters of data collected
through its implementation of the Recovering Quality of Life
(ReQoL) measure. This patient-reported outcome measure (PROM)
assesses the quality of life for individuals with various mental
health conditions.
The ReQoL assessment, now a standard component of Ontrak's
clinical model, has provided valuable insights into factors
impacting mental health across diverse populations. ReQoL
assessments are intended to evaluate the impact of mental health
conditions, psychological interventions, and healthcare
interventions on members’ lives because they focus on understanding
the person over the diagnosis, consistent with modern
recovery-oriented strategies. Integrating this tool in Ontrak's
WholeHealth+ program emphasizes the commitment to measurement
feedback in continually improving mental health care and
outcomes.
Key Findings:
- Prevalence of Poor Quality of Life: Results from
baseline assessments of adults 18 years and older enrolled in the
WholeHealth+ program reveal that 58% of the Medicaid population and
29% of the Commercial population report a poorer quality of life as
compared to the general population.
- Significant Improvements Observed: Ontrak's analysis
shows that 35% of Medicaid and 18% of Commercial members who
completed subsequent assessments have already significantly
improved their ReQoL scores (defined as an increase of 5 or more
points) in follow-up surveys during the two quarters collected
since launch. Ontrak's advanced engagement system and continuous
measurement feedback loop ensure that members receive timely,
targeted support, contributing to these positive outcomes. This
positive trend aligns with the consistently demonstrated
improvements in Depression and Anxiety as measured by PHQ-9 and
GAD-7, which are also PROMs administered in the Ontrak WholeHealth+
program.
Dr. Judith Feld, MD, MPH, MMM, Chief Medical Officer at Ontrak
Health, commented on the findings: "The ReQoL data results provide
us with more nuanced insights into the mental health challenges
faced by our members. The ReQoL measure has proven to be a powerful
tool for uncovering hidden struggles and tracking clinical
progress. Utilizing the ReQoL in our clinical programs has
significantly improved the effectiveness of our tech-enabled
personalized interventions.”
About Ontrak Health
Ontrak Health (Nasdaq: OTRK) is a leading AI and
technology-enabled behavioral healthcare company whose mission is
to help improve the health and save the lives of as many people as
possible. Ontrak identifies, engages, activates, and provides care
pathways to treatment for the most vulnerable members of the
behavioral health population who would otherwise fall through the
cracks of the healthcare system. We engage individuals with
anxiety, depression, substance use disorder, and chronic disease
through personalized care coaching and customized care pathways
that help them receive the treatment and advocacy they need,
despite the socioeconomic, medical, and health system barriers that
exacerbate the severity of their comorbid illnesses. The company's
integrated intervention platform uses AI, predictive analytics, and
digital interfaces combined with dozens of care coach engagements
to deliver improved member health, better healthcare system
utilization, and durable outcomes and savings to healthcare
payors.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240912747147/en/
Company Contact: Brandon LaVerne Chief Executive Officer
blaverne@ontrakhealth.com
Investor Relations: Ryan Halsted Gilmartin Group
investors@ontrakhealth.com
Ontrak (NASDAQ:OTRK)
過去 株価チャート
から 11 2024 まで 12 2024
Ontrak (NASDAQ:OTRK)
過去 株価チャート
から 12 2023 まで 12 2024